A Single Nucleotide Polymorphism in the MGMT Gene is a Novel Prognostic Biomarker in Patients with Metastatic Colorectal Cancer

Journal Title: Journal of Advances in Medicine and Medical Research - Year 2015, Vol 5, Issue 5

Abstract

Background: Discovery of novel biomarkers of prognosis and drug response remains an elusive, yet critical goal. Thus, accurate and rapid screening of an array of pertinent mutations/SNPs is an essential step in cancer management. Methods: Using a high-throughput multiplex PCR microarray technique, we simultaneously screened the mutational status/SNP of 32 hotspots in multiple genes for metastatic colorectal cancer (mCRC) from 126 formalin fixed paraffin embedded samples from 78 patients. The efficacy of the technology was validated by cross-comparison with conventional Sanger sequencing and pyrosequencing. The clinical outcome was corroborated to the mutational status to determine prognostic and predictive significance of the 32 loci. Results: In a statistically robust multivariate model, patients with the TT genotype of the MGMT gene (rs1625649) enjoyed a significantly longer survival (61.8 months) when compared to those with GG or heterozygous GT genotype (29.3 months) [HR 0.30; 95% CI: 0.10-0.89, P= 0.03], with a 70% reduced risk of death from mCRC. Conclusion: The rs1625649 SNP within MGMT is a novel and potentially valuable prognostic biomarker for mCRC patients.

Authors and Affiliations

Radhashree Maitra, Jay B. Nayak, Amartej Merla, Arjun Sood, Titto A. Augustine, Mahadi Baig, David M. Reynolds, John M. Mariadason, Santiago Aparo, Sanjay Goel

Keywords

Related Articles

A Rare Case of Cockayne Syndrome

Background: Cockayne syndrome is a rare autosomal recessive congenital disorder characterized by growth failure, impaired development of the nervous system, abnormal sensitivity to sunlight (photosensitivity), and premat...

Role of Autologous Platelet Derived Growth Factor and Fibrin Rich Plasma in Management of Chronic Non-healing Ulcer–A Pilot Study

Background and Objectives: Chronic non-healing ulcer (CNHU) develops due to infections, trauma or underlying any medical and surgical conditions. Ulcer that have failed to response all available mode of treatment for lon...

Comparison of DNA Extraction Methods for Human Oral Microbiome Research

The oral micro biome is highly diverse and its composition is associated with oral disease and potentially diseases at other sites. Our objective is to evaluate DNA extraction methods potentially suitable for population-...

Spinal Anaesthesia and Neurological Complications: A Brief Report

Spinal anaesthesia is widely performed for lower abdominal, inguinal, and lower extremity operations in routine practice, with a low complication rate. Neurological deficits are rare but significant complications of spin...

Urine Abnormalities and Chronic Kidney Disease in Highly Active Antiretroviral Therapy-naive Adults: A Cross-sectional Study

Objective: This study investigated chronic kidney disease (CKD) and urine abnormalities in highly active antiretroviral therapy naïve (HAART-naïve) human immunodeficiency virus (HIV) infected adults, presenting to two an...

Download PDF file
  • EP ID EP345024
  • DOI 10.9734/BJMMR/2015/12841
  • Views 57
  • Downloads 0

How To Cite

Radhashree Maitra, Jay B. Nayak, Amartej Merla, Arjun Sood, Titto A. Augustine, Mahadi Baig, David M. Reynolds, John M. Mariadason, Santiago Aparo, Sanjay Goel (2015). A Single Nucleotide Polymorphism in the MGMT Gene is a Novel Prognostic Biomarker in Patients with Metastatic Colorectal Cancer. Journal of Advances in Medicine and Medical Research, 5(5), 604-611. https://europub.co.uk/articles/-A-345024